A young Texas woman who says she was fast-tracked into a life-altering double mastectomy as a teenager just won a major legal victory. The Texas Supreme Court ruled that her medical malpractice lawsuit against the therapist who recommended the procedure can move forward, reversing a lower court decision that had thrown the case out.
The ruling marks the first time a state supreme court has allowed a detransitioner's malpractice claim to proceed on the merits, and it could open the courthouse doors for others who regret irreversible gender-transition procedures they underwent as minors.
The plaintiff, Kayla Lovdahl, began identifying as transgender at age 12. By 15, she had undergone a double mastectomy. She has since detransitioned and now identifies as female. Her lawsuit targets the licensed therapist who, she alleges, recommended the surgery after minimal evaluation and without adequate informed consent.
Lovdahl's legal team argues the therapist failed to meet the standard of care by rubber-stamping a radical, irreversible surgical procedure on a minor without properly screening for co-occurring mental health conditions that may have driven the gender dysphoria. Those conditions, her attorneys contend, should have been treated first.
The therapist's defense had argued that the claims were barred under existing legal frameworks and that the standard of care at the time supported the so-called "gender-affirming" model. A lower court agreed and dismissed the suit. The Texas Supreme Court disagreed and sent the case back.
In its opinion, the Texas Supreme Court found that Lovdahl had presented sufficient expert evidence to establish that the therapist's conduct fell below the accepted standard of care. The court held that the lower court applied the wrong legal standard in dismissing the case at the preliminary stage.
The decision does not declare the therapist liable. It simply clears the path for the lawsuit to proceed to discovery and, potentially, trial. But the legal significance is hard to overstate. By letting the claim survive, the court signaled that gender-transition treatment decisions involving minors are not immune from ordinary malpractice scrutiny.
As Fox News reported on the ruling, the decision has been described as "landmark" by legal observers on both sides of the debate. It establishes a procedural precedent that detransitioners can use expert testimony to challenge the adequacy of the care they received before undergoing permanent body-altering surgeries.
Lovdahl has been vocal about her experience. She has described the process that led to her surgery as rushed and inadequate, saying she was a troubled adolescent who needed mental health treatment, not a mastectomy.
"I was a child. I needed help, not surgery."
Her case has become a rallying point for critics of the gender-affirming care model, which prioritizes supporting a patient's stated gender identity and, in some cases, provides hormonal and surgical interventions to minors. Supporters of that model argue it is evidence-based and reduces suicide risk. Critics counter that the evidence base is weak, that many adolescents desist from transgender identification without intervention, and that irreversible procedures should never be performed on minors who cannot fully grasp the consequences.
Until now, detransitioners seeking accountability through the courts have faced steep obstacles. Medical malpractice claims require expert testimony establishing a departure from the standard of care. Because major medical organizations in the United States have broadly endorsed gender-affirming protocols, finding credentialed experts willing to testify against those protocols has been difficult.
The Texas Supreme Court's willingness to credit Lovdahl's expert evidence on the standard-of-care question is what makes this ruling a potential turning point. It suggests that courts need not defer automatically to professional-organization position statements when individual practitioners are accused of failing specific patients. CLN previously covered the procedural developments in Lovdahl's case as it moved through the Texas court system.
Several European countries, including the United Kingdom, Sweden, and Finland, have already pulled back sharply from pediatric gender-transition interventions after independent reviews found the evidence supporting them to be low quality. The Cass Review in England, completed in 2024, concluded that children had been let down by a lack of research and an ideologically driven clinical culture. Courts in those countries have begun scrutinizing whether minors can meaningfully consent to treatments with permanent effects.
With the Texas Supreme Court's ruling in hand, Lovdahl's case returns to the trial court. Discovery will likely focus on the therapist's clinical records, the evaluation process before surgery was recommended, and whether alternative diagnoses were explored or dismissed.
The therapist's legal team can still mount a defense on the merits, arguing that the care provided was consistent with prevailing clinical guidelines at the time. But they will now have to make that argument before a fact-finder, not on a motion to dismiss. That distinction matters. Malpractice cases that survive to discovery often produce documents and testimony that reshape the public understanding of how decisions were made behind closed doors.
Investigators and attorneys in the case will need to determine what clinical documentation existed before the surgery referral, whether the therapist conducted or reviewed any psychological testing, and how much time elapsed between the initial evaluation and the surgical recommendation. Those facts will be central to whether a jury ultimately finds the therapist fell short.
Texas has already enacted legislation restricting gender-transition procedures for minors. Governor Greg Abbott and the state legislature moved in 2023 to ban most surgical and hormonal interventions for children with gender dysphoria. The Lovdahl case, however, addresses conduct that predates those restrictions and tests whether the legal system can provide a remedy after the fact.
That question matters beyond Texas. Thousands of American minors have received puberty blockers, cross-sex hormones, or surgeries under the gender-affirming model in recent years. If even a fraction of them later detransition and seek legal recourse, the precedent set by this ruling will shape whether they can get into a courtroom at all.
The medical establishment's response to the ruling has been muted so far. No major medical organization has issued a public statement on the decision. Authorities in the professional therapy and surgical communities have not publicly confirmed whether they plan to revise clinical guidelines in light of the growing legal and political pressure.
For Lovdahl, the fight is personal. She lost parts of her body that she cannot get back. The legal system is now telling her she at least deserves the chance to ask why it happened and whether anyone should be held responsible.
The Texas Supreme Court did not decide whether Kayla Lovdahl was wronged. It decided she has the right to try to prove it. In a legal environment where detransitioners have struggled to get past procedural gatekeeping, that alone shifts the ground.
When adults perform irreversible surgery on a child, the law should have something to say about whether anyone bothered to ask the hard questions first. Texas just said it does.
